MIGNOGNA, CARMEN
 Distribuzione geografica
Continente #
NA - Nord America 328
EU - Europa 307
AS - Asia 106
AF - Africa 9
SA - Sud America 4
Totale 754
Nazione #
US - Stati Uniti d'America 320
IT - Italia 197
SG - Singapore 57
SE - Svezia 37
IN - India 23
BG - Bulgaria 15
CN - Cina 14
IE - Irlanda 10
UA - Ucraina 10
CA - Canada 7
DE - Germania 6
FR - Francia 6
FI - Finlandia 5
GB - Regno Unito 5
TG - Togo 5
BE - Belgio 3
RO - Romania 3
CH - Svizzera 2
CO - Colombia 2
HK - Hong Kong 2
JP - Giappone 2
MY - Malesia 2
PH - Filippine 2
PL - Polonia 2
TR - Turchia 2
ZA - Sudafrica 2
AL - Albania 1
AR - Argentina 1
CL - Cile 1
EG - Egitto 1
HU - Ungheria 1
IL - Israele 1
LU - Lussemburgo 1
LV - Lettonia 1
ME - Montenegro 1
MX - Messico 1
RU - Federazione Russa 1
TZ - Tanzania 1
UZ - Uzbekistan 1
Totale 754
Città #
Rome 85
Chandler 63
Fairfield 31
Singapore 23
Sofia 15
Ashburn 14
Princeton 13
San Paolo di Civitate 13
Seattle 13
Wilmington 13
Woodbridge 13
New York 11
Dublin 10
Cambridge 9
Milan 9
San Diego 9
Houston 8
Lawrence 8
Millbury 7
Boardman 6
Boston 6
Induno Olona 6
Lomé 5
Helsinki 4
Venafro 4
Andover 3
Ann Arbor 3
Barrie 3
Hebei 3
London 3
Molfetta 3
Philadelphia 3
Toronto 3
Beijing 2
Bern 2
Bogotá 2
Brussels 2
Catanzaro 2
Chicago 2
Como 2
Dearborn 2
Fremont 2
Hong Kong 2
Istanbul 2
Johannesburg 2
Köthen 2
Latina 2
Lingolsheim 2
Menlo Park 2
Nagoya 2
Nagpur 2
Osimo 2
Osoppo 2
Plano 2
Redwood City 2
Santarcangelo di Romagna 2
Shanghai 2
Villaricca 2
Acquedolci 1
Antwerp 1
Bremen 1
Budapest 1
Casoria 1
Cerveteri 1
Clifton 1
Dallas 1
Des Moines 1
Edinburgh 1
Federal 1
Fort Lauderdale 1
Fulham 1
General Santos 1
Guangzhou 1
Guidonia 1
Hefei 1
Hyderabad 1
Kota Kinabalu 1
Lappeenranta 1
Las Vegas 1
Livorno 1
Los Angeles 1
Luxembourg 1
Mannheim 1
Mexico City 1
Montreal 1
Moscow 1
Naples 1
Norwalk 1
Nuremberg 1
Paris 1
Pleasantville 1
Podgorica 1
Portici 1
Sacramento 1
San Mateo 1
Shimla 1
Stockholm 1
Tashkent 1
Taytay 1
Tel Aviv 1
Totale 514
Nome #
Cardiometabolic multimorbidity is associated with a worse Covid-19 prognosis than individual cardiometabolic risk factors. A multicentre retrospective study (CoViDiab II) 100
Clinical features of patients with type 2 diabetes with and without Covid-19: a case control study (CoViDiab I) 83
Impact of cardiovascular disease on clinical outcomes in hospitalized patients with Covid-19. a systematic review and meta-analysis 78
Chitotriosidase Activity Is Inversely Associated with Diastolic Blood Pressure and HbA1c but Not with Arterial Stiffness in Patients with Type 2 Diabetes without Complications 58
Adult-onset autoimmune diabetes in 2020: an update 57
Decrease of coronary heart disease risk with GLP1-receptor agonists or SGLT2 inhibitors therapy in patients with type 2 diabetes in primary cardiovascular prevention: a 24 months follow-up study 55
Effects of the COVID-19 lockdown on glycaemic control in subjects with type 2 diabetes: the glycalock study 54
Espressione di sclerostina nelle placche aterosclerotiche di pazienti sottoposti a tea carotidea 46
Short-term safety profile of Sars-Cov2 vaccination on glucose control. Continuous glucose monitoring data in people with autoimmune diabetes 44
Short-term effectiveness of dapagliflozin versus {DPP}-4 inhibitors in elderly patients with type 2 diabetes: a multicentre retrospective study 41
Livelli aumentati di sclerostina in corso di diabete mellito tipo 2 e complicanze macrovascolari 40
Diastolic Pressure And Acr Are Modifiable Risk Factors Of Arterial Stiffness In T2DM Without Cardiovascular Disease 40
Development of a clinical risk score to predict death in patients with COVID-19 33
Investigational therapies targeting CD3 for prevention and treatment of type 1 diabetes 27
Reduced early response to SARS-CoV2 vaccination in people with type 1 and type 2 diabetes, a six months follow-up study. The CoVaDiab study I 25
Sex Differences in Cardiovascular Disease and Cardiovascular Risk Estimation in Patients With Type 1 Diabetes 17
Lack of Association between Serum Chitotriosidase Activity and Arterial Stiffness in Type 2 Diabetes without Cardiovascular Complications 14
Saxagliptin/dapagliflozin is non‐inferior to insulin glargine in terms of β‐cell function in subjects with latent autoimmune diabetes in adults: A 12‐month, randomized, comparator‐controlled pilot study 12
Hepatic steatosis with significant fibrosis is associated with an increased 10-year estimated risk of cardiovascular disease in adults with type 1 diabetes mellitus 6
MASLD, hepatic steatosis and fibrosis are associated with the prevalence of chronic kidney disease and retinopathy in adults with type 1 diabetes mellitus 6
No differences in kidney function decline between people with type 2 diabetes starting a sodium-glucose cotransporter 2 inhibitor or a glucagon-like peptide-1 receptor agonist: a real-world retrospective comparative observational study 6
null 3
Association between different modalities of insulin administration and metabolic dysfunction-associated fatty liver disease in adults with type 1 diabetes mellitus 1
Totale 846
Categoria #
all - tutte 3.158
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.158


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202018 2 0 0 0 0 2 6 2 2 2 1 1
2020/2021119 2 2 0 1 3 17 1 4 28 12 24 25
2021/2022203 0 2 5 31 17 17 19 13 13 15 35 36
2022/2023273 30 35 24 44 16 32 8 25 24 13 17 5
2023/2024210 11 9 15 10 25 22 11 15 6 35 21 30
2024/202516 16 0 0 0 0 0 0 0 0 0 0 0
Totale 846